Confirmed: Boston Scientific to buy Endo's urology portfolio for $1.65B

Boston Scientific confirms speculation with a $1.65 billion bid for Endo International's urology business, not including its star-crossed American Medical Systems pelvic mesh business.

Boston Scientific, Endo Health

News Well, Men's Health, Mergers & Acquisitions, Urology

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1APerdy